Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional Laser and Tranexamic Acid for Melasma
NCT03963466Completed
- Start
- May 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tranexamic acid in melasma (4 arms). Primary endpoints: Melasma Area and Severity Index at 36 weeks, Antera 3D Skin Analysis at 36 weeks and 1 more. Started May 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on NCT03963466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03963466.